Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Ablation Stories

2012-08-22 02:23:47

MARLBOROUGH, Mass., Aug. 22, 2012 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that its technology will be highlighted in two presentations during the European Society of Cardiology (ESC) Congress 2012, in Munich, Germany, August 25-29. In addition, the technology will be featured at an evening academic symposium, where cardiology thought leaders will discuss their experiences with...

2012-08-12 23:01:33

To build upon our medical and surgical expertise and research to provide breakthrough technology to produce the next standard of visual outcomes. Toronto ON (PRWEB) August 12, 2012 Laser Eye Surgery Toronto News with Dr Andrew Taylor. Dr. Andrew Taylor, MD, FRCSC, Dip ABO is a cum laude graduate of the University of Toronto. Dr. Taylor received his medical degree from the University of Toronto in 1991. He then completed an internship in comprehensive internal medicine at The Toronto...

shutterstock_45324409
2012-08-10 17:32:48

Lee Rannals for redOrbit.com - Your Universe Online Researchers are attempting to create futuristic surgical gloves that can allow doctors to perform ultrasound scans through the tips of their fingers. Scientists have created devices that are capable of responding with high precision to the stresses and strains associated with touch and finger movement. In order to create these devices, they had to be able to mimic and recreate the intricate properties of the fingertips through using...

2012-07-26 06:23:57

In laboratory study, University of Michigan develops cell-specific technique using photodynamic therapy and nanotechnology for more precise cardiac ablation ANN ARBOR, Mich., July 26, 2012 /PRNewswire-USNewswire/ -- University of Michigan heart researchers are shedding light on a safer method for steadying an abnormal heart rhythm that prevents collateral damage to healthy cells. Irregular heart rhythms, or arrhythmias, set the stage for a common, debilitating disorder called...

2012-07-25 06:37:53

By: Katie Williams, Ivanhoe Health Correspondent (Ivanhoe Newswire)- Researchers have completed the first study of a procedure which uses three dimensional maps to determine the location of electrical signals in children´s hearts. This could help cardiologists correct rapid heart rhythms in young patients. Children who have atrioventricular nodal reentrant tachycardia, or AVNRT, suffer from disruptions in the heart's electrical system that causes sudden rapid heart rates. Patients...

2012-07-24 13:05:54

University of Michigan heart researchers are shedding light on a safer method for steadying an abnormal heart rhythm that prevents collateral damage to healthy cells. Irregular heart rhythms, or arrhythmias, set the stage for a common, debilitating disorder called atrial fibrillation that puts adults as young as age 40 at risk for fatigue, fainting, cardiac arrest, and even death. Medications can help, but doctors also use catheter ablation in which electrical impulses are delivered to a...

2012-07-24 10:12:22

American Heart Association meeting report: BCVS-12 Abstract 25 The first study of a procedure to make three-dimensional "maps" of electrical signals in children's hearts could help cardiologists correct rapid heart rhythms in young patients, according to new research presented at the American Heart Association's Basic Cardiovascular Sciences 2012 Scientific Sessions. Children with the condition atrioventricular nodal reentrant tachycardia, or AVNRT, suffer from disruptions in the...

2012-07-11 02:25:25

GULF SHORES, Ala., July 11, 2012 /PRNewswire/ -- Many patients find that after receiving image-guided cancer ablation, their bodies experience an anti-cancer immune response in which their immune system attacks untreated live tumors. Dr. Jason R. Williams of the American Cancer Ablation Center and Precision Imaging (http://www.cancerablation.com) is taking measures to enhance this response by combining the body's natural reaction to an ablated tumor with injections of immune-stimulating...

2012-06-13 02:27:33

MARLBOROUGH, Mass., June 13, 2012 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that a unique study in the journal Heart Rhythm demonstrates high acute success (98%) and durable pulmonary vein (PV) isolation rates achievable with a single, visually-guided HeartLight EAS ablation procedure. To determine durability, the study involved a subsequent diagnostic remapping procedure that...

2012-06-04 02:26:19

MARLBOROUGH, Mass., June 4, 2012 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces new worldwide data with its technology was presented during the scientific sessions at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA last month. The research, representing the first 400 patients treated solely with the HeartLight system,...